Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Lumberfeverlongon Dec 07, 2015 9:53am
114 Views
Post# 24360856

RE:I know what CXR guided

RE:I know what CXR guidedNet income is not a proper measure of a company's abiulity to generate cash flow as it already takes into account interest expense, taxes, depreciation and amortization.  I believe EBIT is the more relevant measure to evaluate the potential impact of the AMCO acquisition on 2016 results.  At the end of the day, CXR forecasted in excess of $600 mm of EBITDA and in excess of $300 mm in net earnings for 2016.  I believe EPS was forecasted to be between US $6.20 to US $6.80 per share.   That leaves plenty of cash pay to down debt after having paid interest.  This looks good from any perspective and any selective review of the AMCO acquisition is disingenuous.
<< Previous
Bullboard Posts
Next >>